FSHR and polycystic ovary syndrome: Some animal studies have also evaluated the effect of myo-inositol and d-chiro-inositol in the treatment of PCOS and have shown that a 40:1 ratio of the two positively modulates the steroidogenic pathway of the ovarian theca cells and increases the concentration of FSH receptors in granulosa cells [35].